Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum.
scientific article published on 04 June 2008
.jpg/500px-Malaria_Parasite_Connecting_to_Human_Red_Blood_Cell_(34034143483).jpg)